Jameson, K. ., Amber, V. ., D’Oca, K. ., Mills, D. ., Giles, A. ., & Ambegaonkar, B. . (2013). Impact of lipid-lowering therapy on the prevalence of dyslipidaemia in patients at high-risk of cardiovascular events in UK primary care - a retrospective database study. Int J Clin Pract. http://doi.org/10.1111/ijcp.12238
K. D'Oca
First name
K.
Last name
D'Oca
Das, R. ., Langerman, H. ., D’Oca, K. ., & Strongman, H. . (2014). An Observational Cohort Study of Diabetes-Associated Secondary Health Care Utilisation in Patients With Type 2 Diabetes Prescribed Dual Combination Therapy With Oral Anti-Hyperglycaemic Agents in the UK. Value Health. http://doi.org/10.1016/j.jval.2014.08.782
Jameson, K. ., D’Oca, K. ., Murray-Thomas, T. ., O\textquoterightRegan, C. ., & Leigh, P. . (2014). Adherence to Nice Guidance For Initiating Glp-1 Mimetics Among Patients With Type 2 Diabetes In Primary Care In England And Wales - An Evaluation Using The Clinical Practice Research Datalink (Cprd). Value Health. http://doi.org/10.1016/j.jval.2014.08.794
Strongman, H. ., D’Oca, K. ., Langerman, H. ., & Das, R. . (2015). Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12458
Jameson, K. ., D’Oca, K. ., Leigh, P. ., & Murray-Thomas, T. . (2016). Adherence to NICE guidance on glucagon-like peptide-1 receptor agonists among patients with type 2 diabetes mellitus: an evaluation using the Clinical Practice Research Datalink. Curr Med Res Opin. http://doi.org/10.1185/03007995.2015.1101372